141 related articles for article (PubMed ID: 33865302)
1. Causes and outcomes of hypereosinophilia in a tropical country.
Chanswangphuwana C; Uaprasert N; Moonla C; Rojnuckarin P
Asian Pac J Allergy Immunol; 2021 Apr; ():. PubMed ID: 33865302
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.
Helbig G; Hus M; Francuz T; Dziaczkowska-Suszek J; Soja A; Kyrcz-Krzemień S
Med Oncol; 2014 Jan; 31(1):815. PubMed ID: 24338273
[TBL] [Abstract][Full Text] [Related]
3. Causes of hypereosinophilia in 100 consecutive patients.
Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic Hypereosinophilia: A Multicenter Retrospective Analysis.
Rhyou HI; Lee SE; Kim MY; Park CS; Jo EJ; Choi GS; Nam YH
J Asthma Allergy; 2022; 15():1763-1771. PubMed ID: 36531904
[TBL] [Abstract][Full Text] [Related]
5. Marked and persistent eosinophilia in the absence of clinical manifestations.
Chen YY; Khoury P; Ware JM; Holland-Thomas NC; Stoddard JL; Gurprasad S; Waldner AJ; Klion AD
J Allergy Clin Immunol; 2014 Apr; 133(4):1195-202. PubMed ID: 23987798
[TBL] [Abstract][Full Text] [Related]
6. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting.
Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Trehan A; Varma S
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018052. PubMed ID: 30210745
[TBL] [Abstract][Full Text] [Related]
7. Natural history of severe eosinophilia with uncertain aetiology and proposals on a practical approach to its management.
Ang AL; Wong RX; Zhuang QY; Linn YC
Intern Med J; 2012 Aug; 42(8):928-33. PubMed ID: 22151137
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of hypereosinophilic syndrome first presenting with asthma-like symptoms.
Wei X; Li X; Wei Z; Zhang H; Deng J; Xing S; Zhang J
Ann Med; 2022 Dec; 54(1):11-21. PubMed ID: 34935570
[TBL] [Abstract][Full Text] [Related]
9. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Valent P; Klion AD; Roufosse F; Simon D; Metzgeroth G; Leiferman KM; Schwaab J; Butterfield JH; Sperr WR; Sotlar K; Vandenberghe P; Hoermann G; Haferlach T; Moriggl R; George TI; Akin C; Bochner BS; Gotlib J; Reiter A; Horny HP; Arock M; Simon HU; Gleich GJ
Allergy; 2023 Jan; 78(1):47-59. PubMed ID: 36207764
[TBL] [Abstract][Full Text] [Related]
10. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
11. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
Hu Z; Wang W; Thakral B; Chen Z; Estrov Z; Bueso-Ramos CE; Verstovsek S; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2021 May; 100(3):352-360. PubMed ID: 32157815
[TBL] [Abstract][Full Text] [Related]
13. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
[TBL] [Abstract][Full Text] [Related]
15. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract][Full Text] [Related]
16. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
[TBL] [Abstract][Full Text] [Related]
17. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract][Full Text] [Related]
18. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
[TBL] [Abstract][Full Text] [Related]
19. [The Lymphoid Variant of HES (L-HES) as Differential Diagnose of Severe Asthma in Childhood].
Leu T; Rauthe S; Wirth C; Simon HU; Kunzmann V; Hebestreit H; Kunzmann S
Klin Padiatr; 2016 Nov; 228(6-07):319-324. PubMed ID: 27846662
[TBL] [Abstract][Full Text] [Related]
20. Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome.
Torcida N; Casalino G; Bondue A; Jodaitis L; Vanden Eynden F; Roufosse F
Front Cardiovasc Med; 2023; 10():1256862. PubMed ID: 37829688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
